BEMIPHARM
Business purpose.
étude et réalisations compris construction en tant que contractant général, promoteur dans la construction de bâtiments dans le secteur pharmaco industriel, de la santé et de la cosmétique
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Sundry professional, scientific and technical activities (74.90B)
- Sector
- Other professional, scientific and technical activities
- Headcount
- 3 to 5 employees
- Created
- 8 Mar 2023
- Share capital
- 100,000.00 EUR
- Establishments
- 2
Directors
- EXELMANS ADVISORY Commissaire aux comptes titulaire
- GROUPE BEMING President de SAS
Other companies at the same address
39 other company head offices are registered at this address.
Establishments
-
94975230700023 37000 TOURS
Financial strength
Financial score
49 / 100 D
Confidence: medium · computed on the financial year ended 31 Dec 2024
- Equity to assets (4.8 %)
- 5.2 out of 30
- EBITDA margin (6.9 %)
- 12.9 out of 25
- Liquidity (240.4 %)
- 10.5 out of 20
- Debt (41.0 %)
- 10.1 out of 15
- Revenue trend (2,520.8 %)
- 10.0 out of 10
formula fin-1.0
Legal score
87 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (3.7 years)
- 7.4 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 2,540,873 € | +2,520.8 % | 175,159 € | 131,936 € |
| 31 Dec 2023 | 96,950 € | first year on record | -5,129 € | -8,444 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale des bureaux d'études techniques, des cabinets d'ingénieurs-conseils et des sociétés de conseils du 15 décembre 1987.
IDCC 1486 · in force, extended · 1 establishment · declared in August 2026
Legal notices
-
Filing of accounts 17 Sep 2026
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260178, annonce n 12528 · Proof of publication (PDF)
-
Amendment 8 Sep 2026
- Court :
- Greffe du Tribunal de Commerce d'Evry
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20260171, annonce n 9698 · Proof of publication (PDF)
-
Filing of accounts 13 Jul 2025
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250133, annonce n 8024 · Proof of publication (PDF)
-
Filing of accounts 8 Jan 2025
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20250005, annonce n 3265 · Proof of publication (PDF)
-
Incorporation 14 Mar 2023
- Court :
- Greffe du Tribunal de Commerce d'Evry
BODACC A n 20230051, annonce n 2335 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 22 Dec 2025
- Formality 2 Jun 2023
Change history
- Change in the register 4 Nov 2026
- Change in the register 3 Nov 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 10 Oct 2026
- Appointed: President de SAS 10 Oct 2026
- Appointed: Commissaire aux comptes titulaire 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Commissaire aux comptes titulaire 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Share capital: 100,000 € 2 Oct 2026
- Registered office: 3 Avenue de la Baltique 91140 Villebon-sur-Yvette 1 Oct 2026
Frequently asked questions about BEMIPHARM
- What is the SIREN number of BEMIPHARM?
- The SIREN number of BEMIPHARM is 949752307. Its intra-community VAT number is FR79949752307.
- Where is the head office of BEMIPHARM?
- Head office address: 3 AVENUE DE LA BALTIQUE, 91140 VILLEBON-SUR-YVETTE.
- When was BEMIPHARM founded?
- BEMIPHARM was founded on 8 Mar 2023.
- What does BEMIPHARM do?
- Its declared main activity is: Sundry professional, scientific and technical activities (NAF code 74.90B).
- Who runs BEMIPHARM?
- The officers listed in the register are EXELMANS ADVISORY (Commissaire aux comptes titulaire), GROUPE BEMING (President de SAS).
- What is the revenue of BEMIPHARM?
- The latest published revenue is 2,540,873 €, for the 2024 financial year.
- How many employees does BEMIPHARM have?
- The declared headcount is 3 to 5 employees. Insee data for 2024.
- Is BEMIPHARM subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.